To determine whether PDA regulates the endothelial barrier through activation of the NRP1/VEGFR2/VE-Cad signaling pathway, we knocked down NRP1 in HUVECs using small interfering RNA (siRNA) that specifically targeted NRP1. The gene discussed is NRP1; the disease is Patent ductus arteriosus.